» Articles » PMID: 21801699

Nanotechnology for Therapy and Imaging of Liver Diseases

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2011 Aug 2
PMID 21801699
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Nanotechnology has been considered for the improved delivery of various therapeutic agents, including drugs and genes. Indeed, liposomes and nanoparticles equipped with homing devices for the targeting of receptors over-expressed on the hepatic tissue have improved the treatment of various liver diseases. In this review, various nanotechnology approaches employed for the treatment/imaging of liver disease, either in preclinical or in clinic are discussed.

Citing Articles

Navigating liver cancer: Precision targeting for enhanced treatment outcomes.

Jain A, Mishra A, Hurkat P, Shilpi S, Mody N, Jain S Drug Deliv Transl Res. 2025; .

PMID: 39847205 DOI: 10.1007/s13346-024-01780-x.


Nanomedicine Strategies Utilizing Lipid-Based Nanoparticles for Liver Cancer Therapy: Exploring Signaling Pathways and Therapeutic Modalities.

Asgharzadeh F, Moradi Binabaj M, Fanoudi S, Cho W, Yang Y, Azarian M Adv Pharm Bull. 2024; 14(3):513-523.

PMID: 39494254 PMC: 11530870. DOI: 10.34172/apb.2024.061.


Evaluation of the therapeutic potential of novel nanoparticle formulations of glutathione and virgin coconut oil in an experimental model of carbon tetrachloride-induced liver failure.

Allam E, Darwish M, Abou Khalil N, El-Baset S, El-Aal M, Elrawy A BMC Pharmacol Toxicol. 2024; 25(1):74.

PMID: 39380023 PMC: 11460069. DOI: 10.1186/s40360-024-00795-x.


Engineered SPIONs functionalized with endothelin a receptor antagonist ameliorate liver fibrosis by inhibiting hepatic stellate cell activation.

Ten Hove M, Smyris A, Booijink R, Wachsmuth L, Hansen U, Alic L Bioact Mater. 2024; 39:406-426.

PMID: 38855059 PMC: 11157122. DOI: 10.1016/j.bioactmat.2024.05.034.


Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance.

Kusumoputro S, Au C, Lam K, Park N, Hyun A, Kusumoputro E Nanomaterials (Basel). 2024; 14(1).

PMID: 38202522 PMC: 10780512. DOI: 10.3390/nano14010067.